Industry News

More Industry News

Image title

AstraZeneca partners with Torrent to launch branded generics
3/11/2010
Cel-Sci receives Byron's marketing fee for cancer drug candidate
3/10/2010
Novartis takes option for Transgene's cancer vaccine
3/10/2010

AstraZeneca partners with Torrent to launch branded generics

3/11/2010

AstraZeneca agreed to brand and market 18 generic drugs owned by Torrent Pharmaceuticals in nine emerging markets. "The products were carefully selected in therapy areas we're strong in. We believe we can be successful in building market share and brand equity," said Renaud Savary, head of AstraZeneca's branded-generics unit.

Regulatory News

Image title

FDA will look into risk of femur fractures in bisphosphonates
3/11/2010
Cytokinetics' ALS treatment receives FDA's orphan-drug designation
3/10/2010
FDA adds boxed warning to blood disorder drug WinRho SDF
3/10/2010

FDA will look into risk of femur fractures in bisphosphonates

3/11/2010

The FDA will investigate the safety of bisphosphonates, drugs used to treat bone conditions including osteoporosis, in light of reports associating them with atypical subtrochanteric femur fractures. The agency said it did not find a clear connection between the medicines and side effects in data submitted by drug manufacturers.

Online Newsletters

Kudos to companies extending themselves with superior manufacturing practices
02/10/2010
Boosting manufacturing efficiency: A look at new industry efforts
01/13/2010
Outsourcing API manufacturing – is the tide turning away from Asia?
12/09/2009
New CDC report, old lesson: Sterility in manufacturing is crucial
11/11/2009

As a Registered INTERPHEX365 Subscriber, you will be receiving monthly INTERPHEX365 Reporter newsletters electronically. This online publication, published in cooperation with SmartBrief, will summarize the highlights of each month with unique commentary on the industry news.

Issues of past monthly newsletters will be stored here in an Archive.

If you haven't already done so, we encourage you to Register to take full advantage of site functionality, including industry news and participation in the Business Discussion Forums.

Sign-up to receive the INTERPHEX365 Reporter